Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

1.15
-0.0900-7.26%
Post-market: 1.170.0200+1.74%16:15 EDT
Volume:93.00K
Turnover:109.25K
Market Cap:51.91M
PE:-1.48
High:1.25
Open:1.25
Low:1.15
Close:1.24
52wk High:1.60
52wk Low:0.5011
Shares:45.14M
Float Shares:21.59M
Volume Ratio:0.43
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-3.27
PE(LYR):-1.39

Loading ...

Lake Street Sticks to Its Buy Rating for TELA Bio (TELA)

TIPRANKS
·
Yesterday

TELA Bio gains short-term relief on loan covenants

TIPRANKS
·
Yesterday

TELA Bio - Enters Consent to Credit Agreement on Sept 28, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

TELA Bio Secures Lender Consent to Waive Minimum Revenue Covenant Tests for Q3, Q4 2026

Reuters
·
Yesterday

TELA Bio Initiated at Buy by Craig-Hallum

Dow Jones
·
Sep 26

Craig Hallum Initiates Coverage on TELA Bio With Buy Rating, $2 Price Target

MT Newswires Live
·
Sep 25

TELA Bio Director Joseph H. Capper Acquires Common Shares Worth USD 88,845.00

Reuters
·
Sep 19

TELA Bio Faces NASDAQ Delisting Notice After Failing $1 Minimum Bid Rule

Reuters
·
Sep 19

Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA), Oscar Health (OSCR) and Brookdale Senior Living (BKD)

TIPRANKS
·
Sep 17

Insider Move at TELA Bio Signals Growing Confidence From the Top

TIPRANKS
·
Sep 17

TELA Bio Director Joseph H. Capper Acquires USD 78,449 in Common Shares

Reuters
·
Sep 17

TELA Bio Announces Special Shareholder Meeting

Reuters
·
Sep 05

Analyst Reaffirms Buy on TELA Bio, Citing Restructuring-Driven Cost Savings and Steady $2 Price Target

TIPRANKS
·
Sep 01

TELA Bio - Roberto Cuca Steps Down as COO and CFO Effective August 31, 2026

THOMSON REUTERS
·
Aug 31

TELA Bio - Anticipates One-Time Restructuring Charge of About $1.50 Mln in Q3 2026

THOMSON REUTERS
·
Aug 31

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

THOMSON REUTERS
·
Aug 31

TELA Bio - to Reduce Headcount by About 20%

THOMSON REUTERS
·
Aug 31

TELA Bio - to Reduce Annual Operating Expenses by About $17 Mln

THOMSON REUTERS
·
Aug 31

TELA Bio - Expects Cost Reduction Initiative to Extend Cash Runway into 2028

THOMSON REUTERS
·
Aug 31

TELA Bio CEO Heather Getz Acquires 12,500 Common Shares Valued at $8,311.25

Reuters
·
Aug 20